Browse

Explore conditions, clinical trials, and the organisations running them.

Up to: Digestive system neuroendocrine tumor, grade 1/2 · Pancreatic neuroendocrine neoplasm

Pancreatic neuroendocrine tumor

Pancreatic endocrine tumor, also known as pancreatic neuroendocrine tumor (PNET), describes a group of endocrine tumors originating in the pancreas that are usually indolent and benign, but may have the potential to be malignant. They can be functional, exhibiting a hormonal hypersecretion syndrome, but can be non-functional presenting with non-specific symptoms and include insulinoma, glucagonoma, VIPoma, somatostatinoma (SSoma), PPoma and Zollinger-Ellison syndrome (ZES, or gastrinoma) and other ectopic hormone producing tumors (such as GRFoma).

60 trials tagged with this condition →

Functional pancreatic neuroendocrine tumor 1 trial · 14 incl. sub-types Sub-types →
Pancreatic insulin-producing neuroendocrine tumor 0 trials · 13 incl. sub-types Sub-types →
Somatostatinoma 6 trials
Pancreatic neuroendocrine tumor G1 1 trial · 5 incl. sub-types Sub-types →
Non-functional pancreatic neuroendocrine tumor 4 trials Sub-types →
Glucagonoma 2 trials
Pancreatic gastrin-producing neuroendocrine tumor 2 trials Sub-types →
PPoma 1 trial
VIPoma 1 trial Sub-types →
GRFoma 0 trials
Pancreatic delta cell neuroendocrine tumor 0 trials Sub-types →